TickerFacts.

Regencell Bioscience Holdings Ltd (RGC): Capital Expenditures

Annual figures by period end, from SEC filings.

$152.7K
Year ended 2025-06-30
-42.0%
3-year compound annual growth
+5.3%
5-year compound annual growth
$780.9K2020-06-30: $117.8K2022-06-30: $780.9K2023-06-30: $27.4K2024-06-30: $5.4K2025-06-30: $152.7K$152.7K
2020-06-30 Capital Expenditures (USD) 2025-06-30
Period endedCapital ExpendituresChange YoYSource filing
2025-06-30$152.7Kn/m2026-10-07, From 2024-07-01
2024-06-30$5.4K-80.4%2026-10-07, From 2023-07-01
2023-06-30$27.4K-96.5%2025-10-31, From 2022-07-01
2022-06-30$780.9Kn/a2024-10-25, From 2021-07-01
No annual figure between 2020-06-30 and 2022-06-30.
2020-06-30$117.8Kn/a2022-10-31, From 2019-07-01

Capital Expenditures at similar companies

Companies with the same SEC industry code (Medicinal Chemicals & Botanical Products), reporting in the same currency, closest in revenue. Each shows its own latest fiscal year, so period ends differ.

CompanyYear endedCapital ExpendituresChange YoY
Regencell Bioscience Holdings Ltd (RGC)2025-06-30$152.7Kn/m
Charlie's Holdings, Inc. (CHUC)2025-12-31$23.0Kn/a
Functional Brands Inc. (MEHA)2025-12-31$8.5K+352.6%
Mannatech Inc (MTEX)2025-12-31$1.35M+355.6%
Leef Brands Inc. (LEEEF)2025-12-31$642.0K-89.2%
TFA Therapeutics, Inc. (RAJAF)2024-12-31$349.2K+9.3%
C21 Investments Inc. (CWLXF)2026-03-31$244.8K-39.8%
Bon Natural Life Ltd (BON)2025-09-30$6.8K-3.1%
Fitlife Brands, Inc. (FTLF)2025-12-31$42.0K+320.0%

Compare RGC, CHUC, MEHA, MTEX side by side · Screen every company in Medicinal Chemicals & Botanical Products ↗